Amrutanjan Health Care Ltd.

•

amrutanjan.comBSE: 590006NSE: AMRUTANJAN

Market Cap₹ 1,464 Cr.

Current Price

High / Low₹ 791 / 483

Stock P/E27.1

Book Value₹ 130

Price to Book5.72

Dividend Yield0.97 %

ROCE22.6 %

ROE16.5 %

Face Value₹ 1

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2025 • OTC Products: 64.2% • Women Hygiene: 27.4% • Beverages: 8.1%

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Company is almost debt free
Company has a healthy return on capital (ROCE) of 21.1%
Company has a consistent dividend-paying track record
Company generates healthy free cash flow

CONS

Promoter holding has decreased over last 2 years: -4.1pp
A large part of profit comes from other income (25.6% of PBT)
Operating margins have contracted to 12.9% from 23.4%
Stock is trading at 5.7x its book value
Growth is decelerating - 3Y profit CAGR (-8.9%) trails the 5Y trend (15.2%)

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	SUNPHARMA	1899.00	37.67	455633.71	0.84	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9100.00	82.59	241576.41	0.33	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4850.00	84.58	184478.41	0.78	566.00	3.28	4921.00	57.32	19.27	33.81
4.	CIPLA	1385.00	33.19	111888.39	0.94	785.55	-39.18	7119.28	4.13	16.00	16.73
5.	ZYDUSLIFE	1121.00	24.78	111820.18	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
6.	LAURUSLABS	1840.00	90.93	99417.45	0.11	362.07	123.94	2026.31	29.10	18.20	31.50
7.	LUPIN	2111.00	17.46	96528.82	0.85	1416.98	16.01	8276.89	34.28	28.86	29.59
8.	DRREDDY	1154.00	29.89	96322.06	0.69	435.60	-69.10	8099.80	-5.21	13.75	10.63
9.	MANKIND	2328.55	47.09	96179.61	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
10.	AUROPHARMA	1653.30	25.62	95127.23	0.24	1032.03	25.22	9150.35	17.44	12.76	20.54
11.	GLENMARK	2427.00	38.10	68495.93	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	AMRUTANJAN	506.25	69.22	1463.60	0.97	4.37	-47.46	102.97	9.48	22.58	6.06

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	78	99	117	127	84	110	123	135	94	118	141	150	103
	71	92	95	111	80	96	99	118	86	101	116	124	99
Operating Profit	7	7	22	16	4	14	23	18	8	17	25	26	4
OPM %	9.18%	6.89%	18.44%	12.77%	4.24%	12.38%	19.02%	13.07%	8.98%	14.04%	17.85%	17.05%	4.16%
	4	4	4	5	4	4	4	5	4	4	3	-3	6
Interest	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	1	2	2	2	2	2	2	2	2	2	2	2	2
Profit before Tax	9	9	24	20	6	16	26	21	11	19	26	21	6
Tax %	25.66%	25.62%	26.40%	30.34%	27.24%	26.04%	25.93%	27.23%	26.40%	27.33%	26.21%	22.93%	28.08%
Net Profit	7	7	17	14	5	12	19	15	8	14	19	16	4
	2.40	2.36	6.05	4.72	1.60	4.08	6.66	5.25	2.87	4.83	6.73	5.60	1.51

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
	184	212	220	253	261	333	406	380	421	452	511
	153	182	192	222	231	266	328	335	369	394	440
Operating Profit	32	30	28	31	31	67	78	45	52	58	72
OPM %	17.12%	14.06%	12.86%	12.21%	11.79%	20.20%	19.11%	11.73%	12.32%	12.91%	13.98%
	6	7	8	7	8	19	17	15	16	18	10
Interest	0	1	0	0	0	1	1	0	0	0	0
Depreciation	3	3	3	3	4	4	4	5	6	7	7
Profit before Tax	35	34	33	35	34	82	91	54	62	69	73
Tax %	35.14%	35.19%	39.16%	29.32%	27.20%	25.29%	25.82%	25.74%	27.40%	26.47%	25.71%
Net Profit	22	22	20	25	25	61	67	40	45	51	54
EPS	0.00	0.00	13.67	0.00	8.58	20.93	22.98	13.63	15.56	17.58	—
Dividend Payout %	25.10%	25.81%	28.43%	25.64%	24.47%	20.06%	20.01%	33.76%	29.57%	26.16%	—

COMPOUNDED SALES GROWTH

10 Years:: 11%
5 Years:: 12%
3 Years:: 4%

COMPOUNDED PROFIT GROWTH

10 Years:: 12%
5 Years:: 15%
3 Years:: -9%

STOCK PRICE CAGR

10 Years:: 9%
5 Years:: -7%
3 Years:: -8%
1 Year:: -31%

RETURN ON EQUITY

10 Years:: 20%
5 Years:: 21%
3 Years:: 15%
Last Year:: 17%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	3	3	3	3	3	3	3	3	3	3
	118	113	126	143	157	212	262	287	286	323
	0	3	0	0	1	1	0	1	2	2
Trade Payables	9	25	26	30	31	41	60	47	56	69
	19	5	7	7	9	14	21	20	17	21
Total Liabilities	149	149	162	183	201	271	346	358	364	418
	22	27	28	26	26	23	28	49	50	49
Capital Work in Progress	1	1	0	0	0	0	16	1	2	16
	10	10	8	18	18	18	13	5	0	0
	8	10	10	15	24	17	26	29	29	27
	0	0	0	0	26	0	0	0	48	56
Cash & Bank	48	31	73	81	36	139	88	70	27	83
	60	71	44	44	70	73	175	203	208	186
Total Assets	149	149	162	183	201	271	346	358	364	418

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
	33	22	30	31	18	110	76	36	28	51
Cash from Investing	1	-0	-8	-11	-14	-88	-36	-2	19	-31
Cash from Financing	-11	-5	-9	-7	-12	-7	-17	-15	-48	-13
	12	3	2	3	-7	-4	-1	3	-1	6

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
PER SHARE
EPS (₹)	15.34	14.92	13.72	8.39	8.58	20.93	22.99	13.63	15.56	17.58
Book Value (₹)	82.43	79.17	88.03	49.86	54.54	73.53	90.49	99.12	99.92	112.83
Dividend per Share (₹)	3.85	3.85	3.90	2.15	2.10	4.20	4.60	4.60	4.60	4.60
Cash EPS (₹)	8.53	8.44	7.85	9.50	10.07	22.19	24.28	15.41	17.65	19.84
PROFITABILITY
Operating Margin %	19.30%	16.70%	16.33%	15.05%	11.79%	25.89%	23.40%	15.56%	12.32%	12.91%
Net Margin %	11.60%	9.82%	9.05%	9.67%	9.59%	18.38%	16.56%	10.49%	10.68%	11.25%
ROE %	19.90%	18.46%	16.41%	17.87%	16.44%	32.69%	28.03%	14.37%	15.54%	16.53%
ROCE %	30.86%	28.65%	26.95%	25.43%	22.80%	44.00%	37.93%	19.38%	21.47%	22.58%
	16.07%	14.66%	12.89%	14.18%	13.05%	25.94%	21.78%	11.32%	12.47%	13.00%
EFFICIENCY
Debtor Days	50	45	47	44	41	24	25	34	35	42
Inventory Days	14	15	17	18	27	23	20	26	25	23
Payable Days	81	72	98	86	95	94	102	108	89	102
	-17	-12	-35	-25	-27	-47	-58	-48	-29	-38
FINANCIAL HEALTH
Debt to Equity (x)	0.00x	0.02x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x
Interest Coverage (x)	173.68x	61.33x	106.83x	172.19x	102.57x	139.35x	156.66x	241.99x	247.90x	213.00x
	3.76x	3.35x	3.75x	3.87x	3.22x	4.28x	3.55x	4.13x	4.23x	3.44x
GROWTH
Revenue Growth %	12.89%	14.77%	3.96%	15.17%	3.20%	27.29%	21.93%	-6.46%	10.96%	7.26%
Operating Profit Growth %	27.02%	-0.61%	-2.40%	5.44%	2.65%	120.08%	10.20%	-37.78%	15.53%	11.33%
Net Profit Growth %	30.98%	-2.76%	-8.03%	22.27%	2.32%	143.95%	9.80%	-40.71%	12.90%	13.03%
	0.00%	0.00%	0.00%	0.00%	2.32%	0.00%	0.00%	0.00%	14.15%	13.04%
VALUATION
P/E (x)	0.00x	0.00x	0.00x	0.00x	38.45x	0.00x	0.00x	0.00x	39.77x	36.67x
P/B (x)	0.00x	0.00x	0.00x	0.00x	6.05x	0.00x	0.00x	0.00x	6.19x	5.72x
Dividend Yield %	0.00%	0.00%	0.00%	0.00%	0.64%	0.00%	0.00%	0.00%	0.74%	0.71%
	0.00x	0.00x	0.00x	0.00x	23.71x	0.00x	0.00x	0.00x	25.82x	23.44x

Shareholding Pattern

Numbers in percentages

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	50.59	46.52	46.52	46.52	46.52	46.52	46.52	46.52	46.52
	1.55	2.34	2.30	2.30	2.41	2.38	2.27	2.17	2.44
	7.32	10.60	11.13	11.41	12.70	12.90	13.00	12.66	12.29
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	40.54	40.54	40.06	39.77	38.37	38.20	38.22	38.65	38.76

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-08-28

Updates

2026-08-28 - Amrutanjan Health Care Limited has informed the Exchange regarding 'BRSR for the FY 2025-26'.

2026-08-28

Shareholders meeting

2026-08-28 - Amrutanjan Health Care Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 23, 2026

2026-08-12

Investor Presentation

2026-08-12 - Amrutanjan Health Care Limited has informed the Exchange about Investor Presentation

2026-08-11

Record Date

2026-08-11 - Amrutanjan Health Care Limited has informed the Exchange that Record date for the purpose of Dividend & Meeting is 11-Sep-2026.

2026-08-11

Outcome of Board Meeting

2026-08-11 - Amrutanjan Health Care Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

2026-08-05

Commencement of commercial production/operations

2026-08-05 - Amrutanjan Health Care Limited has informed the Exchange about Commencement of commercial production/operations

2026-08-05

Credit Rating

2026-08-05 - Amrutanjan Health Care Limited has informed the Exchange about Credit Rating

2026-08-01

Action(s) taken or orders passed

2026-08-01 - Amrutanjan Health Care Limited has informed the Exchange about Action(s) taken or orders passed

2026-07-08

Certificate under SEBI (Depositories and Participants) Regulations, 2018

2026-07-08 - Amrutanjan Health Care Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

News

Recent coverage and analyst commentary for AMRUTANJAN

Loading news…

🤖

AI Stock Analyst

Amrutanjan Health Care Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account